These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 31027664)

  • 1. Recognition and Management of Malaria.
    Gerstenlauer C
    Nurs Clin North Am; 2019 Jun; 54(2):245-260. PubMed ID: 31027664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malaria Surveillance - United States, 2016.
    Mace KE; Arguin PM; Lucchi NW; Tan KR
    MMWR Surveill Summ; 2019 May; 68(5):1-35. PubMed ID: 31099769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malaria Surveillance - United States, 2017.
    Mace KE; Lucchi NW; Tan KR
    MMWR Surveill Summ; 2021 Mar; 70(2):1-35. PubMed ID: 33735166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of atovaquone-proguanil chemoprophylaxis and chloroquine treatment in Plasmodium malariae infection.
    Visser R; de Mast Q; Munnix I; van der Ven A; Dofferhoff T
    Travel Med Infect Dis; 2016; 14(6):644-645. PubMed ID: 27546283
    [No Abstract]   [Full Text] [Related]  

  • 5. Malaria Surveillance - United States, 2014.
    Mace KE; Arguin PM
    MMWR Surveill Summ; 2017 May; 66(12):1-24. PubMed ID: 28542123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-free Holidays: Compliance, Tolerability, and Acceptability of a 3-Day Atovaquone/Proguanil Schedule for Pretravel Malaria Chemoprophylaxis in Australian Travelers.
    Lau CL; Ramsey L; Mills LC; Furuya-Kanamori L; Mills DJ
    Clin Infect Dis; 2019 Jun; 69(1):137-143. PubMed ID: 30281083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malaria Surveillance - United States, 2013.
    Cullen KA; Mace KE; Arguin PM;
    MMWR Surveill Summ; 2016 Mar; 65(2):1-22. PubMed ID: 26938139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Questionnaire-based analysis of atovaquone-proguanil compared with mefloquine in the chemoprophylaxis of malaria in non-immune Japanese travelers.
    Kato T; Okuda J; Ide D; Amano K; Takei Y; Yamaguchi Y
    J Infect Chemother; 2013 Feb; 19(1):20-3. PubMed ID: 22740189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malaria surveillance--United States, 2012.
    Cullen KA; Arguin PM;
    MMWR Surveill Summ; 2014 Dec; 63(12):1-22. PubMed ID: 25474160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review: Malaria chemoprophylaxis for travelers to Latin America.
    Steinhardt LC; Magill AJ; Arguin PM
    Am J Trop Med Hyg; 2011 Dec; 85(6):1015-24. PubMed ID: 22144437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relapsing malaria: two cases of malaria presenting 8 months after return from Africa despite adherence to antimalarial chemoprophylaxis.
    Morgan GS; Chiodini P; Evans M
    Br J Gen Pract; 2012 Oct; 62(603):555-6. PubMed ID: 23265223
    [No Abstract]   [Full Text] [Related]  

  • 12. Antimalarial pharmacology and therapeutics of atovaquone.
    Nixon GL; Moss DM; Shone AE; Lalloo DG; Fisher N; O'Neill PM; Ward SA; Biagini GA
    J Antimicrob Chemother; 2013 May; 68(5):977-85. PubMed ID: 23292347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The conundrum of malaria chemoprophylaxis.
    Shanks D
    J Travel Med; 2016 Jun; 23(6):. PubMed ID: 27694470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knowledge, attitudes, and practices regarding antimalarial chemoprophylaxis in U.S. Peace Corps Volunteers--Africa, 2013.
    Landman KZ; Tan KR; Arguin PM;
    MMWR Morb Mortal Wkly Rep; 2014 Jun; 63(23):516-7. PubMed ID: 24918487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atovaquone-proguanil chemoprophylaxis in the era of Tafenoquine.
    Meltzer E; Schwartz E
    J Travel Med; 2019 Jun; 26(4):. PubMed ID: 30535377
    [No Abstract]   [Full Text] [Related]  

  • 16. Malaria chemoprophylaxis regimens: a descriptive drug utilization study.
    Bloechliger M; Schlagenhauf P; Toovey S; Schnetzler G; Tatt I; Tomianovic D; Jick SS; Meier CR
    Travel Med Infect Dis; 2014; 12(6 Pt B):718-25. PubMed ID: 24934849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of twice a week prophylaxis with atovaquone-proguanil (Malarone®) in long-term travellers to West Africa.
    Lachish T; Bar-Meir M; Eisenberg N; Schwartz E
    J Travel Med; 2016 Jun; 23(6):. PubMed ID: 27625401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of chemoprophylaxis against malaria with chloroquine plus proguanil, mefloquine, and atovaquone plus proguanil in travelers from Denmark.
    Kofoed K; Petersen E
    J Travel Med; 2003; 10(3):150-4. PubMed ID: 12757688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malaria chemoprophylaxis: what do the travelers choose, and how does pretravel consultation influence their final decision.
    Senn N; D'Acremont V; Landry P; Genton B
    Am J Trop Med Hyg; 2007 Dec; 77(6):1010-4. PubMed ID: 18165513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmodium falciparum malaria occurring four years after leaving an endemic area.
    Vantomme B; Van Acker J; Rogge S; Ommeslag D; Donck J; Callens S
    Acta Clin Belg; 2016 Apr; 71(2):111-3. PubMed ID: 26312505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.